Dr. Shiyanbola’s research examines patient perceptions and roles in the quality of medication use and its impact on medication adherence, health literacy and the elimination of health disparities. Specifically, Dr. Shiyanbola studies the perceptions of illness and medicines among underserved populations. She explores how to utilize and interweave patient perspectives into the development of tailored patient-centered medication use interventions.
Dr. Shiyanbola’s KL2 research project is entitled Development of a Culturally Appropriate Medication Adherence Intervention for African Americans with Type 2 Diabetes. She will use a health and social psychology approach and mixed methods to explore African Americans’ illness beliefs through qualitative focus groups, leading to subsequent adaptation of an illness beliefs questionnaire, and psychometric testing and quantitative survey to establish the questionnaire’s validity and reliability. Her goal is to lay the ground work for the development of a culturally-appropriate medication adherence intervention for African Americans with type 2 diabetes, setting the stage for large scale studies of intervention effectiveness, dissemination, and implementation across communities and practice settings.
For her KL2 project, Dr. Shiyanbola will be working with various African American Community Partners in Wisconsin including a Milwaukee-based Community Advisory Board led by CCHE Affiliate, Ms. Gina Green-Harris. Ms. Green-Harris is Director of Milwaukee Outreach Programs & Services for the Wisconsin Alzheimer Institute.
Dr. Shiyanbola is Assistant Professor in the UW School of Pharmacy Social and Administrative Sciences Division.
Congratulations and best of luck!